IDEX Biometrics ASA
IDXAF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $72 | $156 | $667 |
| - Cash | $2 | $11 | $16 | $34 |
| + Debt | $3 | $7 | $12 | $0 |
| Enterprise Value | $1 | $68 | $152 | $633 |
| Revenue | $1 | $4 | $4 | $3 |
| % Growth | -80.9% | 1.5% | 44.1% | – |
| Gross Profit | -$11 | $0 | $1 | $2 |
| % Margin | -1,445.5% | 5.6% | 20.7% | 55.8% |
| EBITDA | -$9 | -$274 | -$30 | -$30 |
| % Margin | -1,146.4% | -6,595.7% | -731.2% | -1,040% |
| Net Income | -$14 | -$27 | -$33 | -$33 |
| % Margin | -1,718.1% | -643.4% | -798.1% | -1,146.1% |
| EPS Diluted | -1.75 | -55.857 | -76.37 | -76.964 |
| % Growth | 96.9% | 26.9% | 0.8% | – |
| Operating Cash Flow | -$18 | -$27 | -$32 | -$27 |
| Capital Expenditures | $16 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$18 | -$27 | -$32 | -$28 |